Facts and challenges for the autoimmunologist. Lessons from the second Colombian autoimmune symposium

Autoimmunity Reviews

Volumn 11, Issue 4, 2012, Pages 249-251

  Anaya, Juan Manuel ^a,d   Shoenfeld, Yehuda ^b   Cervera, Ricard ^c  

^a UNIVERSIDAD DEL ROSARIO   (Colombia)

^b SHEBA MEDICAL CENTER   (Israel)

^c HOSPITAL CLÍNIC   (Spain)

^d NONE   (Colombia)

Author keywords

[No Author keywords available]

Indexed keywords

HEAT SHOCK PROTEIN;

ANTIBODY DETECTION; AUTOIMMUNE DISEASE; B LYMPHOCYTE; COLOMBIA; CYTOMEGALOVIRUS; EDITORIAL; EPSTEIN BARR VIRUS; HEALTH CARE; HEREDITY; HUMAN; MEDICAL SPECIALIST; PHYSICIAN; RISK FACTOR; SJOEGREN SYNDROME; SYMPOSIUM; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS;

EID: 84857039713     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2011.10.001     Document Type: Editorial

References (54)

1. Anaya J.M. Autoimmunity and autoimmune disease: a Colombian construction beyond deconstructions. Autoimmun Rev 2006, 5:165-166.
2. Becker K.G., Simon R.M., Bailey-Wilson J.E., Freidlin B., Biddison W.E., McFarland H.F., et al. Clustering of non-major histocompatibility complex susceptibility candidate loci in human autoimmune diseases. Proc Natl Acad Sci U S A 1998, 95:9979-9984.
3. Correa P.A., Gomez L.M., Cadena J., Anaya J.M. Autoimmunity and tuberculosis. Opposite association with TNF polymorphism. J Rheumatol 2005, 32:219-224.
4. Gomez L.M., Anaya J.M., Gonzalez C.I., Pineda-Tamayo R., Otero W., Arango A., et al. PTPN22 C1858T polymorphism in Colombian patients with autoimmune diseases. Genes Immun 2005, 6:628-631.
5. Anaya J.M., Gómez L., Castiblanco J. Is there a common genetic basis for autoimmune diseases?. Clin Dev Immunol 2006, 13:185-195.
6. Castiblanco J., Anaya J.M. The nature and nurture of common autoimmunity. Ann N Y Acad Sci 2007, 1109:1-8.
7. Delgado-Vega A.M., Castiblanco J., Gómez L.M., Diaz-Gallo L.M., Rojas-Villarraga A., Anaya J.M. Bcl-2 antagonist killer 1 (BAK1) polymorphisms influence the risk of developing autoimmune rheumatic diseases in women. Ann Rheum Dis 2010, 69:462-465.
8. Mamtani M., Anaya J.M., He W., Ahuja S.K. Association of copy number variation in the FCGR3B gene with risk of autoimmune diseases. Genes Immun 2010, 11:155-160.
9. Anaya J.M. The autoimmune tautology. Arthritis Res Ther 2010, 12:147.
10. Cotsapas C., Voight B.F., Rossin E., Lage K., Neale B.M., Wallace C., et al. Pervasive sharing of genetic effects in autoimmune disease. PLoS Genet 2011, 7:e1002254.
11. Deshmukh H.A., Maiti A.K., Kim-Howard X.R., Rojas-Villarraga A., Guthridge J.M., Anaya J.M., et al. Evaluation of 19 autoimmune disease-associated loci with rheumatoid arthritis in a Colombian population: evidence for replication and gene-gene interaction. J Rheumatol 2011, 38:1866-1870.
12. Shoenfeld Y., Selmi C., Zimlichman E., Gershwin M.E. The autoimmunologist: geoepidemiology, a new center of gravity, and prime time for autoimmunity. J Autoimmun 2008, 31:325-330.
13. Shoenfeld Y., Gershwin M.E. Preface. The autoimmunologist and the congresses of autoimmunity. Ann N Y Acad Sci 2009, 1173:1-3.
14. Matthias T., Shoenfeld Y. Challenges for the autoimmunologist. Clin Rev Allergy Immunol 2010, 38:75-76.
15. Barabas A.Z., Cole C.D., Graeff R.M., Lafreniere R., Weir D.M. The role of autoimmunologists in investigating and treating autoimmune disorders. Autoimmun Rev 2011, 10:166-170.
16. Lorber M., Gershwin M.E., Shoenfeld Y. The coexistence of systemic lupus erythematosus with other autoimmune diseases: the kaleidoscope of autoimmunity. Semin Arthritis Rheum 1994, 24:105-113.
17. Weiss P., Shoenfeld Y. Shifts in autoimmune diseases: the kaleidoscope of autoimmunity. Isr J Med Sci 1991, 27:215-217.
18. Shoenfeld Y. The kaleidoscope of autoimmunity. Autoimmunity 1993, 15:245-252.
19. Anaya J.M., Corena R., Castiblanco J., Rojas-Villarraga A., Shoenfeld Y. The kaleidoscope of autoimmunity: multiple autoimmune syndromes and familial autoimmunity. Expert Rev Clin Immunol 2007, 3:623-635.
20. Shoenfeld Y., Isenberg D.A. The mosaic of autoimmunity. Immunol Today 1989, 10:123-126.
21. Shoenfeld Y., Isenberg D.A. Autoimmune diseases - clinical features and animal models. The Mosaic of Autoimmunity 1989, Elsevier, New York.
22. Cervera R. The epidemiology and significance of autoimmune diseases in health care. Scand J Clin Lab Invest Suppl 2001, 235:27-30.
23. Anaya J.M., Tobon G.J., Vega P., Castiblanco J. Autoimmune disease aggregation in families with primary Sjögren's syndrome. J Rheumatol 2006, 33:2227-2234.
24. Anaya J.M., Castiblanco J., Tobón G.J., García J., Abad V., Cuervo H., et al. Familial clustering of autoimmune diseases in patients with type 1 diabetes mellitus. J Autoimmun 2006, 26:208-214.
25. Hudson M., Rojas-Villarraga A., Coral-Alvarado P., López-Guzmán S., Mantilla R.D., Chalem P., et al. Polyautoimmunity and familial autoimmunity in systemic sclerosis. J Autoimmun 2008, 31:156-159.
26. Rojas-Villarraga A., Toro C.E., Espinosa G., Rodríguez-Velosa Y., Duarte-Rey C., Mantilla R.D., et al. Factors influencing polyautoimmunity in systemic lupus erythematosus. Autoimmun Rev 2010, 9:229-232.
27. Vasconcelos C., Cervera R. Networking in Europe for special centres of excellence for autoimmune diseases. Lupus 2009, 18:930-932.
28. Vasconcelos C. Do we need autoimmune disease units in hospitals?. Ann N Y Acad Sci 2009, 1173:4-9.
29. Selmi C. The worldwide gradient of autoimmune conditions. Autoimmun Rev 2010, 9:A247-A250.
30. Cervera R., Font J., Shoenfeld Y. European Working Party on Systemic Lupus Erythematosus. European Working Party on Systemic Lupus Erythematosus: a 15-year report. Autoimmun Rev 2006, 5:549-553.
31. Cervera R., Khamashta M.A., Shoenfeld Y., Camps M.T., Jacobsen S., Kiss E., et al. Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicentre prospective study of 1000 patients. Ann Rheum Dis 2009, 68:1428-1432.
32. Cervera R., Bucciarelli S., Plasín M.A., Gómez-Puerta J.A., Plaza J., Pons-Estel G., et al. Catastrophic antiphospholipid syndrome (CAPS): descriptive analysis of a series of 280 patients from the "CAPS Registry". J Autoimmun 2009, 32:240-245.
33. Erkan D., Espinosa G., Cervera R. Catastrophic antiphospholipid syndrome: updated diagnostic algorithms. Autoimmun Rev 2010, 10:74-79.
34. Youinou P., Pers J.O. The international symposium on Sjögren's syndrome in Brest: the "top of the tops" at the "tip of the tips". Autoimmun Rev 2010, 9:589-590.
35. Tobón G.J., Pers J.O., Youinou P., Saraux A. B cell-targeted therapies in Sjögren's syndrome. Autoimmun Rev 2010, 9:224-228.
36. Chizzolini C., Brembilla N.C., Montanari E., Truchetet M.E. Fibrosis and immune dysregulation in systemic sclerosis. Autoimmun Rev 2011, 10:276-281.
37. Grossman C., Dovrish Z., Shoenfeld Y., Amital H. Do infections facilitate the emergence of systemic sclerosis?. Autoimmun Rev 2011, 10:244-247.
38. García-Carrasco M., Ramos M., Cervera R., Font J., Vidal J., Muñoz F.J., et al. Hepatitis C virus infection in primary Sjögren's syndrome: prevalence and clinical significance in a series of 90 patients. Ann Rheum Dis 1997, 56:173-175.
39. Barzilai O., Sherer Y., Ram M., Izhaky D., Anaya J.M., Shoenfeld Y. Epstein-Barr virus and cytomegalovirus in autoimmune diseases: are they truly notorious? A preliminary report. Ann N Y Acad Sci 2007, 1108:567-577.
40. Shoenfeld Y., Blank M., Abu-Shakra M., Amital H., Barzilai O., Berkun Y., et al. The mosaic of autoimmunity: prediction, autoantibodies, and therapy in autoimmune diseases-2008. Isr Med Assoc J 2008 Jan, 10:13-19.
41. Souberbielle J.C., Body J.J., Lappe J.M., Plebani M., Shoenfeld Y., Wang T.J., et al. Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: recommendations for clinical practice. Autoimmun Rev 2010, 9:709-715.
42. Arnson Y., Shoenfeld Y., Amital H. Effects of tobacco smoke on immunity, inflammation and autoimmunity. J Autoimmun 2010, 34:J258-J265.
43. Kiss E., Kovacs L., Szodoray P. Malignancies in systemic lupus erythematosus. Autoimmun Rev 2010, 9:195-199.
44. Tincani A., Taraborelli M., Cattaneo R. Antiphospholipid antibodies and malignancies. Autoimmun Rev 2010, 9:200-202.
45. van de Schans S.A., van Spronsen D.J., Hooijkaas H., Janssen-Heijnen M.L., Coebergh J.W. Excess of autoimmune and chronic inflammatory disorders in patients with lymphoma compared with all cancer patients: a cancer registry-based analysis in the south of the Netherlands. Autoimmun Rev 2011, 10:228-234.
46. Zinger H., Sherer Y., Shoenfeld Y. Atherosclerosis in autoimmune rheumatic diseases-mechanisms and clinical findings. Clin Rev Allergy Immunol 2009, 37:20-28.
47. Strous R.D., Shoenfeld Y. Schizophrenia, autoimmunity and immune system dysregulation: a comprehensive model updated and revisited. J Autoimmun 2006, 27:71-80.
48. Colasanti T., Barbati C., Rosano G., Malorni W., Ortona E. Autoantibodies in patients with Alzheimer's disease: pathogenetic role and potential use as biomarkers of disease progression. Autoimmun Rev 2010, 9:807-811.
49. Varin M.M., Guerrier T., Devauchelle-Pensec V., Jamin C., Youinou P., Pers J.O. In Sjögren's syndrome, B lymphocytes induce epithelial cells of salivary glands into apoptosis through protein kinase C delta activation. Autoimmun Rev 2012, 11:252-258.
50. Tobón G.J., Pers J.O., Cañas C.A., Rojas-Villarraga A., Youinou P., Anaya J.M. Are autoimmune diseases predictable?. Autoimmun Rev 2012, 11:259-266.
51. Lessard C.J., Ice J.A., Adrianto I., Wiley G., Kelly J.A., Gaffney P.M., Montgomery C.G., Moser K.L. The genomics of autoimmune disease in the era of genome-wide association studies and beyond. Autoimmun Rev 2012, 11:267-275.
52. Anaya J.M., Kim-Howard X., Prahalad S., Cherñavsky A., Cañas C., Rojas-Villarraga A., et al. Evaluation of genetic association between an ITGAM non-synonymous SNP (rs1143679) and multiple autoimmune diseases. Autoimmun Rev 2012, 11:276-280.
53. Cruz-Tapias P., Rojas-Villarraga A., Maier-Moore S. Anaya JM. HLA and Sjögren's syndrome susceptibility. A meta-analysis of worldwide studies. Autoimmun Rev 2012, 11:281-287.
54. Galarza-Maldonado C., Kourilovitch M.R., Pérez-Fernández O.M., Gaybor M., Cordero C., Cabrera S., et al. Obstetric antiphospholipid syndrome. Autoimmun Rev 2012, 11:288-295.